Steatosis shifts the histopathological heterogeneity of liver metastases towards poor prognosis replacement growth in colorectal cancer patients

Accession: GSE292820
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: bulk RNA-seq)
Modality / assay: bulk-RNAseq
Platform: Expression profiling by high throughput sequencing, 34475
Organism: mouse
Samples: 6
Size (indexed): (None bytes)
Downloaded bytes: 1.2 MB (1235867 bytes)
Access / raw: public /

Download

Files

FileSizeSHA256
GSE292820_DESeq2GSEAColumnDescription.txt.gz938 Bb69ff9124197a62b…
GSE292820_DESeq2results.txt.gz778.1 KB2de4f5d8e4d7c667…
GSE292820_GSEAresults.txt.gz8.2 KB3a699629d6f67955…
GSE292820_GeneSets_mmKEGGmet.gmt.txt.gz13.1 KBd5be2425916d036c…
GSE292820_rawCounts.txt.gz406.7 KB72af563bd4355a8f…

Crawled by masld-atlas-crawler v1.0 at 2026-08-06T03:58:26Z.

About this dataset

This Expression profiling by high throughput sequencing, 34475 dataset provides single-cell gene expression from mouse liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 6 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.